|
1
|
Atagi S, Kawahara M, Yokoyama A, Okamoto
H, Yamamoto N, Ohe Y, Sawa T, Ishikura S, Shibata T, Fukuda H, et
al: Thoracic radiotherapy with or without daily low-dose
carboplatin in elderly patients with non-small-cell lung cancer: A
randomised, controlled, phase 3 trial by the Japan Clinical
Oncology Group (JCOG0301). Lancet Oncol. 13:671–678.
2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Jonna S and Subramaniam DS: Molecular
diagnostics and targeted therapies in non-small cell lung cancer
(NSCLC): An update. Dis Med. 27:167–170. 2019.PubMed/NCBI
|
|
3
|
Brown S, Banfill K, Aznar MC, Whitehurst P
and Faivre Finn C: The evolving role of radiotherapy in non-small
cell lung cancer. Br J Radiol. 92(20190524)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Li YL, Hu X, Li QY, Wang F, Zhang B, Ding
K, Tan BQ, Lin NM and Zhang C: Shikonin sensitizes wild-type EGFR
NSCLC cells to erlotinib and gefitinib therapy. Mol Med Rep.
18:3882–3890. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Crooker K, Aliani R, Ananth M, Arnold L,
Anant S and Thomas SM: A review of promising natural
chemopreventive agents for head and neck cancer. Cancer Prev Res
(Phila). 11:441–450. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Breuss JM, Atanasov AG and Uhrin P:
Resveratrol and its effects on the vascular system. Int J Mol Sci.
20(1523)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Athar M, Back JH, Kopelovich L, Bickers DR
and Kim AL: Multiple molecular targets of resveratrol:
Anti-carcinogenic mechanisms. Arch Biochem Biophys. 486:95–102.
2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ko JH, Sethi G, Um JY, Shanmugam MK,
Arfuso F, Kumar AP, Bishayee A and Ahn KS: The role of resveratrol
in cancer therapy. Int J Mol Sci. 18(2589)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Jiang Z, Chen K, Cheng L, Yan B, Qian W,
Cao J, Li J, Wu E, Ma Q and Yang W: Resveratrol and cancer
treatment: Updates. Ann N Y Acad Sci. 1403:59–69. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Vervandier-Fasseur D and Latruffe N: The
potential use of resveratrol for cancer prevention. Molecules.
24(4506)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pan X, Chen J, Wang W, Chen L, Wang L, Ma
Q, Zhang J, Chen L, Wang G, Zhang M, et al: Resveratrol-induced
antinociception is involved in calcium channels and
calcium/caffeine-sensitive pools. Oncotarget. 8:9399–9409.
2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Xu H, Cheng J, Wang X, Liu H, Wang S, Wu
J, Xu B, Chen A and He F: Resveratrol pretreatment alleviates
myocardial ischemia/reperfusion injury by inhibiting STIM1-mediated
intracellular calcium accumulation. J Physiol Biochem. 75:607–618.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Stephan LS, Almeida ED, Markoski MM,
Garavaglia J and Marcadenti A: Red Wine, resveratrol and atrial
fibrillation. Nutrients. 9(1190)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
So CL, Saunus JM, Roberts-Thomson SJ and
Monteith GR: Calcium signalling and breast cancer. Semin Cell Dev
Biol. 94:74–83. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang Y, He J, Jiang H, Zhang Q, Yang H, Xu
X, Zhang C, Xu C, Wang J and Lu W: Nicotine enhances store-operated
calcium entry by upregulating HIF-1α and SOCC components in
non-small cell lung cancer cells. Oncol Rep. 40:2097–2104.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tang X, Qian LL, Dang SP, Wu Y, Liu XY,
Zhang ZY, Miu LF and Wang RX: Effects of n-3 polyunsaturated fatty
acid on store-operated calcium channels in coronary artery smooth
muscle cells derived from diabetic rat. Zhonghua Xin Xue Guan Bing
Za Zhi. 47:640–646. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
17
|
Wu H: Calcium signaling in platelet
activation. Sheng Li Ke Xue Jin Zhan. 43:417–421. 2012.PubMed/NCBI(In Chinese).
|
|
18
|
Pan Z and Ma J: Open Sesame: Treasure in
store-operated calcium entry pathway for cancer therapy. Sci China
Life Sci. 58:48–53. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ambudkar IS, de Souza LB and Ong HL:
TRPC1, Orai1, and STIM1 in SOCE: Friends in tight spaces. Cell
Calcium. 63:33–39. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lopez JJ, Jardin I, Sanchez-Collado J,
Salido GM, Smani T and Rosado JA: TRPC Channels in the SOCE
Scenario. Cells. 9(126)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Rosenberg P, Katz D and Bryson V: SOCE and
STIM1 signaling in the heart: Timing and location matter. Cell
Calcium. 77:20–28. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Prakriya M and Lewis RS: Store-operated
calcium channels. Physiol Rev. 95:1383–1436. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Collins HE, Zhu-Mauldin X, Marchase RB and
Chatham JC: STIM1/Orai1-mediated SOCE: Current perspectives and
potential roles in cardiac function and pathology. Am J Physiology
Heart Circ Physiol. 305:H446–H458. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lopez E, Frischauf I, Jardin I, Derler I,
Muik M, Cantonero C, Salido GM, Smani T, Rosado JA and Redondo PC:
STIM1 phosphorylation at Y316 modulates its interaction
with SARAF and the activation of SOCE and ICRAC.
J Cell Sci. 132(jcs226019)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ren X, Zhang L, Zhang Y, Mao L and Jiang
H: Mitochondria response to camptothecin and
hydroxycamptothecine-induced apoptosis in Spodoptera exigua cells.
Pestic Biochem Physiol. 140:97–104. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Perry SW, Norman JP, Barbieri J, Brown EB
and Gelbard HA: Mitochondrial membrane potential probes and the
proton gradient: A practical usage guide. Biotechniques. 50:98–115.
2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xie J, Pan H, Yao J, Zhou Y and Han W:
SOCE and cancer: Recent progress and new perspectives. Int J
Cancer. 138:2067–2077. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jardin I and Rosado JA: STIM and calcium
channel complexes in cancer. Biochim Biophys Acta. 1863:1418–1426.
2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tanwar J and Motiani RK: Role of SOCE
architects STIM and orai proteins in cell death. Cell Calcium.
69:19–27. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vokes EE, Govindan R, Iscoe N, Hossain AM,
San Antonio B, Chouaki N, Koczywas M and Senan S: The impact of
staging by positron-emission tomography on overall survival and
progression-free survival in patients with locally advanced NSCLC.
J Thorac Oncol. 13:1183–1188. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Velcheti V, Chandwani S, Chen X, Pietanza
MC and Burke T: First-line pembrolizumab monotherapy for metastatic
PD-L1-positive NSCLC: Real-world analysis of time on treatment.
Immunotherapy. 11:889–901. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wu YL, Yang JC, Kim DW, Lu S, Zhou J, Seto
T, Yang JJ, Yamamoto N, Ahn MJ, Takahashi T, et al: Phase II study
of crizotinib in east asian patients with ROS1-positive advanced
non-small-cell lung cancer. J Clin Oncol. 36:1405–1411.
2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liu X, Gong B, de Souza LB, Ong HL, Subedi
KP, Cheng KT, Swaim W, Zheng C, Mori Y and Ambudkar IS: Radiation
inhibits salivary gland function by promoting STIM1 cleavage by
caspase-3 and loss of SOCE through a TRPM2-dependent pathway. Sci
Signal. 10(eaal4064)2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Voellger B, Waldt N, Rupa R, Kirches E,
Melhem O, Ochel HJ, Mawrin C and Firsching R: Combined effects of
resveratrol and radiation in GH3 and TtT/GF pituitary adenoma
cells. J Neurooncol. 139:573–582. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Fang Y, Bradley MJ, Cook KM, Herrick EJ
and Nicholl MB: A potential role for resveratrol as a radiation
sensitizer for melanoma treatment. J Surg Res. 183:645–653.
2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Tak JK, Lee JH and Park JW: Resveratrol
and piperine enhance radiosensitivity of tumor cells. BMB Rep.
45:242–246. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Chen YA, Lien HM, Kao MC, Lo UG, Lin LC,
Lin CJ, Chang SJ, Chen CC, Hsieh JT, Lin H, et al: Sensitization of
radioresistant prostate cancer cells by resveratrol isolated from
arachis hypogaea stems. PLoS One. 12(e0169204)2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tan Y, Wei X, Zhang W, Wang X, Wang K, Du
B and Xiao J: Resveratrol enhances the radiosensitivity of
nasopharyngeal carcinoma cells by downregulating E2F1. Oncol Rep.
37:1833–1841. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Assad DX, Borges GA, Avelino SR and Guerra
ENS: Additive cytotoxic effects of radiation and mTOR inhibitors in
a cervical cancer cell line. Pathol Res Pract. 214:259–262.
2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Said RS, El-Demerdash E, Nada AS and Kamal
MM: Resveratrol inhibits inflammatory signaling implicated in
ionizing radiation-induced premature ovarian failure through
antagonistic crosstalk between silencing information regulator 1
(SIRT1) and poly(ADP-ribose) polymerase 1 (PARP-1). Biochem
Pharmacol. 103:140–150. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Choi YJ, Heo K, Park HS, Yang KM and Jeong
MH: The resveratrol analog HS-1793 enhances radiosensitivity of
mouse-derived breast cancer cells under hypoxic conditions. Int J
Oncol. 49:1479–1488. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Aravindan S, Natarajan M, Herman TS,
Awasthi V and Aravindan N: Molecular basis of ‘hypoxic’ breast
cancer cell radio-sensitization: Phytochemicals converge on
radiation induced Rel signaling. Radiat Oncol. 8(46)2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Firouzi F, Khoei S and Mirzaei HR: Role of
resveratrol on the cytotoxic effects and DNA damages of
iododeoxyuridine and megavoltage radiation in spheroid culture of
U87MG glioblastoma cell line. Gen Physiol Biophys. 34:43–50.
2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Sener TE, Tavukcu HH, Atasoy BM, Cevik O,
Kaya OT, Cetinel S, Dagli Degerli A, Tinay I, Simsek F, Akbal C, et
al: Resveratrol treatment may preserve the erectile function after
radiotherapy by restoring antioxidant defence mechanisms, SIRT1 and
NOS protein expressions. Int J Impot Res. 30:179–188.
2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Xu L, Yang X, Cai J, Ma J, Cheng H, Zhao
K, Yang L, Cao Y, Qin Q, Zhang C, et al: Resveratrol attenuates
radiation-induced salivary gland dysfunction in mice. Laryngoscope.
123:E23–E29. 2013.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Zhang H, Zhai Z, Wang Y, Zhang J, Wu H,
Wang Y, Li C, Li D, Lu L, Wang X, et al: Resveratrol ameliorates
ionizing irradiation-induced long-term hematopoietic stem cell
injury in mice. Free Radic Biol Med. 54:40–50. 2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Feng Y, Zhou J and Jiang Y: Resveratrol in
lung cancer-a systematic review. J BUON. 21:950–953.
2016.PubMed/NCBI
|
|
48
|
Yousef M, Vlachogiannis IA and Tsiani E:
Effects of resveratrol against lung cancer: In vitro and in vivo
studies. Nutrients. 9(1231)2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Boon N, Hul GB, Viguerie N, Sicard A,
Langin D and Saris WH: Effects of 3 diets with various calcium
contents on 24-h energy expenditure, fat oxidation, and adipose
tissue message RNA expression of lipid metabolism-related proteins.
Am J Clin Nutr. 82:1244–1252. 2005.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Chen X, Hu X, Li Y, Zhu C, Dong X, Zhang
R, Ma J, Huang S and Chen L: Resveratrol inhibits Erk1/2-mediated
adhesion of cancer cells via activating PP2A-PTEN signaling
network. J Cell Physiol. 234:2822–2836. 2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Thiel G and Rössler OG: Resveratrol
stimulates c-Fos gene transcription via activation of ERK1/2
involving multiple genetic elements. Gene. 658:70–75.
2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Soltoff SP and Lannon WA: Activation of
ERK1/2 by store-operated calcium entry in rat parotid acinar cells.
PLoS One. 8(e72881)2013.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Casas-Rua V, Alvarez IS, Pozo-Guisado E
and Martín-Romero FJ: Inhibition of STIM1 phosphorylation underlies
resveratrol-induced inhibition of store-operated calcium entry.
Biochem Pharmacol. 86:1555–1563. 2013.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Rauf A, Imran M, Butt MS, Nadeem M, Peters
DG and Mubarak MS: Resveratrol as an anti-cancer agent: A review.
Crit Rev Food Sci Nutr. 58:1428–1447. 2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Carter LG, D'Orazio JA and Pearson KJ:
Resveratrol and cancer: Focus on in vivo evidence. Endocr Relat
Cancer. 21:R209–R225. 2014.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Howells LM, Berry DP, Elliott PJ, Jacobson
EW, Hoffmann E, Hegarty B, Brown K, Steward WP and Gescher AJ:
Phase I randomized, double-blind pilot study of micronized
resveratrol (SRT501) in patients with hepatic metastases-safety,
pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila).
4:1419–1425. 2011.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Patel KR, Brown VA, Jones DJ, Britton RG,
Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA,
et al: Clinical pharmacology of resveratrol and its metabolites in
colorectal cancer patients. Cancer Res. 70:7392–7399.
2010.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Galiniak S, Aebisher D and
Bartusik-Aebisher D: Health benefits of resveratrol administration.
Acta Biochim Pol. 66:13–21. 2019.PubMed/NCBI View Article : Google Scholar
|
